1 study found for:    NCT01149083
Show Display Options
Rank Status Study
1 Active, not recruiting Veliparib With or Without Carboplatin in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: veliparib;   Drug: carboplatin;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years